The Gemini Brief – Investment Deep Dives

Comprehensive Investment Analysis: Colgate-Palmolive Co. (CL)

All investment deep dives on this site were written by Gemini and Claude LLMs with light human editing. Nothing on this site constitutes investment advice. All materials are for informational purposes only.

The Gemini Brief - Investment Deep Dives
The Gemini Brief – Investment Deep Dives
Comprehensive Investment Analysis: Colgate-Palmolive Co. (CL)
Loading
/

1. Industry Dynamics & Market Structure

A. Global Consumer Staples Sector Overview

The consumer staples sector, comprising companies that manufacture and sell essential products such as food, beverages, household goods, and personal hygiene items, is characterized by its non-cyclical demand patterns. These products maintain relatively stable demand regardless of the prevailing economic conditions, a quality that has earned the sector a “defensive” reputation among investors.1 This resilience was evident in 2022, when the sector outperformed the broader market amidst rising input costs and economic uncertainty.2

Market size estimates for the global consumer staples sector vary, reflecting different methodologies and definitions. One report valued the market at USD 32.93 billion in 2024, projecting it to reach USD 43.92 billion by 2033, representing a compound annual growth rate (CAGR) of 4.2%.1 A separate analysis presents a much larger figure, valuing the market at USD 219.71 billion in 2024 with a projected CAGR of 4.30% to USD 335.44 billion by 2034.3 This discrepancy underscores the importance of focusing on growth rates and underlying trends rather than absolute market size figures.

Key secular trends are shaping the industry’s trajectory. Persistent global population growth, particularly the shift toward urbanization in developing nations, expands the consumer base and alters lifestyles, increasing demand for convenient, ready-to-use products.1 The proliferation of e-commerce has been a revolutionary force, breaking down geographical barriers and enhancing consumer access to a wide array of products.1 Concurrently, there is a pronounced consumer shift toward sustainability, with growing demand for products featuring eco-friendly packaging and ethically sourced ingredients.1

Despite its defensive characteristics, the sector faces significant headwinds. It is highly susceptible to supply chain disruptions stemming from geopolitical tensions, natural disasters, and global health crises, which can lead to raw material shortages and increased production and logistics costs.1 Furthermore, a period of high inflation has tested the pricing power of major brands. While companies were largely successful in passing on price hikes in 2022, this has led to a notable consumer behavioral shift towards private-label goods, particularly in developed markets. In Europe, an estimated 40% of consumers tried a private-label brand in the past year, with household products seeing a 31% brand-switching rate.2 This dynamic creates a challenging environment where companies must balance the need to protect margins through pricing with the risk of losing market share and volume to lower-cost alternatives.

B. Key Market Segments Analysis

Colgate-Palmolive operates within several large and steadily growing sub-sectors of the consumer staples industry.

1. Oral Care Market

The global oral care market is a cornerstone of the consumer staples sector. In 2024, its value was estimated to be between USD 33.63 billion and USD 47.3 billion, with various market research firms projecting a CAGR in the range of 4.25% to 6.4% through the next decade.5 The Asia-Pacific region represents the largest and most dynamic market, accounting for approximately 37% to 43% of global sales, driven by a large aging population and rising consumer demand for herbal and natural products.5

Growth is propelled by an increasing consumer awareness of the link between oral hygiene and overall health, a rising prevalence of dental diseases, and continuous product innovation.5 The toothpaste segment remains the largest product category, commanding between 50% and 56% of the market, fueled by a wide variety of formulations targeting specific consumer needs such as whitening, sensitivity relief, and cavity prevention.5 Competition is intense among established global players; however, in many emerging markets, unorganized local producers present a significant challenge with low-cost alternatives that pressure the pricing strategies of multinational corporations.9

2. Personal Care Market

The personal care market is substantially larger and more fragmented than the oral care market. Size estimates for 2024 range widely from USD 379.88 billion to USD 557.88 billion, with forecasted CAGRs of 4.2% to 7.7%.12 The Asia-Pacific region is the dominant force, leading in both market share and growth rate, propelled by rising disposable incomes and Westernized beauty trends.12

Key market drivers include a heightened focus on personal grooming and hygiene, particularly post-pandemic, and strong demand for anti-aging products from a rapidly aging global population.12 A powerful trend influencing the market is the consumer shift toward products with natural, organic, and sustainable attributes, as individuals become more conscious of the ingredients in their skincare routines.12 The skin care category is the largest segment, accounting for over 32% of the total market, with its growth heavily influenced by the purchasing habits of Gen Z and millennial consumers and the marketing power of social media influencers.12

3. Home Care Market

The home care segment, which includes household cleaners, dishwashing liquids, and fabric conditioners, benefits from similar trends. A heightened post-pandemic focus on household hygiene continues to support baseline demand.2 Key growth drivers in this category are innovation that offers greater convenience, such as automatic dishwashing tablets, and the rapid expansion of e-commerce as a primary distribution channel.17

4. Pet Nutrition Market

The pet nutrition market is a significant and high-growth area. The global market was valued at approximately USD 126.66 billion in 2024 and is projected to grow at a CAGR of 5.52%.18 North America is the largest market, representing over 40% of global sales, driven by high pet ownership rates.18 The primary driver of this market is the “pet humanization” trend, where owners view their pets as family members and are increasingly willing to spend on premium, organic, and science-based nutritional products to support their health and well-being.18 The market is highly concentrated, with Nestlé Purina and Mars Petcare together generating over USD 44 billion in annual revenue, dwarfing all other competitors.21

C. Competitive Landscape & Barriers to Entry

The consumer staples industry is characterized by an oligopolistic structure, dominated by a handful of large, multinational corporations including Procter & Gamble, Unilever, Nestlé, and Colgate-Palmolive.1 These incumbents have established formidable barriers to entry through decades of brand building, massive marketing budgets, extensive global distribution networks, and highly efficient supply chains.4 Securing shelf space with powerful global retailers like Walmart, which can represent over 10% of a single manufacturer’s sales, is a significant hurdle for new entrants.23

Competition remains intense, not only among these established giants but also from two other sources. First, agile local competitors in emerging markets can often respond more quickly to regional consumer tastes and preferences.22 Second, the rise of private-label brands poses a structural threat, especially in periods of economic stress, as consumers become more price-sensitive and willing to trade down from branded products.2 This dynamic is forcing major players to innovate continuously to justify their premium pricing and defend their market share.

2. Company Overview & Competitive Position

A. Business Segments & Geographic Footprint

Colgate-Palmolive Company operates through two primary business segments: Oral, Personal and Home Care and Pet Nutrition.22

  1. Oral, Personal and Home Care: This is the company’s largest segment, accounting for approximately 78% of total net sales in 2024.23 It is further broken down into three product categories:
  • Oral Care (43% of total sales): This is the company’s core business and area of global leadership. Products include toothpaste, manual and electric toothbrushes, mouthwash, and pharmaceutical products for dental professionals. Key brands are Colgate, Darlie, elmex, meridol, Sorriso, and Tom’s of Maine.23
  • Personal Care (18% of total sales): This category includes liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, and skin health products. The portfolio features well-known brands such as Palmolive, Protex, Softsoap, Irish Spring, and Speed Stick, alongside premium, science-based skincare brands like EltaMD, Filorga, and PCA SKIN.23
  • Home Care (17% of total sales): This includes a range of household products such as dishwashing liquids (Ajax, Palmolive), household cleaners (Fabuloso, Murphy), and fabric conditioners (Suavitel).23
  1. Pet Nutrition: Operating under the Hill’s Pet Nutrition brand, this segment represented approximately 22% of total company sales in 2024.23 Hill’s focuses on the premium, science-led segment of the pet food market, offering products through two main brands: Hill’s Science Diet (for wellness) and Hill’s Prescription Diet (for therapeutic needs).25

The company’s geographic presence is highly diversified, with a significant portion of its revenue generated outside of North America. Based on Q3 2024 sales data, the geographic breakdown is as follows: Latin America (23%), Hill’s Pet Nutrition (22%, a global segment), North America (20%), Europe (15%), Asia Pacific (14%), and Africa/Eurasia (6%).26 This substantial exposure to emerging markets offers a long-term growth advantage but also introduces considerable foreign exchange volatility.

B. Market Position & Competitive Advantages (Moat)

Colgate-Palmolive’s primary competitive advantage, or economic moat, is derived from its intangible assets—specifically, its powerful brand equity and global scale.

  • Dominant Market Leadership: The company’s most significant strength is its commanding leadership in the global oral care market. As of the third quarter of 2024, Colgate held a global market share of 41.6% in toothpaste and 32.3% in manual toothbrushes.26 This dominance, built over decades, provides immense pricing power, brand loyalty, and leverage with retailers.
  • Strong Brand Portfolio: The “Colgate” brand is one of the most recognized consumer brands in the world, synonymous with oral hygiene for billions of people. This trust allows the company to introduce new products and enter new sub-segments with a higher probability of success. Brands like Palmolive, Softsoap, and Fabuloso also hold strong positions in their respective categories.23
  • Extensive Global Distribution Network: Colgate’s products are sold in over 200 countries and territories, supported by a vast and deeply entrenched distribution network that would be nearly impossible for a new entrant to replicate.8 This network ensures product availability from modern supermarkets in developed nations to small, independent retailers in rural emerging markets. This scale is crucial, though it also creates concentration risk, with a single customer, Walmart, accounting for 11% of the company’s net sales in 2024.23
  • Premium Position in Pet Nutrition: In the pet nutrition market, Hill’s holds a strong #3 global position and has carved out a defensible niche in the science-backed, premium segment.21 Its strategy of selling through veterinarians and specialty pet stores reinforces its scientific credibility and differentiates it from mass-market competitors.

C. Peer Comparison

An analysis of Colgate-Palmolive’s performance is best understood in the context of its primary competitors in the consumer staples space.

  • Procter & Gamble (PG): As Colgate’s chief rival in oral care, P&G is a larger and more diversified company with its Crest and Oral-B brands. P&G’s strategic focus on “irresistible superiority” is backed by significant R&D investment, leading to innovations like the AI-powered Oral-B iO toothbrush, which has helped grow the entire electric toothbrush category.27 In its fiscal year 2024, P&G’s Oral Care segment grew in the mid-single digits, demonstrating its competitive strength.28
  • Unilever (UL): A global powerhouse with a vast portfolio, Unilever competes with Colgate primarily in Personal Care (Dove, Axe) and, to a lesser extent, in Oral Care (Signal, Closeup), where it holds the #4 global market position.29 In 2024, Unilever’s Personal Care segment generated €13.6 billion in turnover, driven by 5.2% underlying sales growth, highlighting the scale of competition in this category.29
  • Church & Dwight (CHD): Though smaller, Church & Dwight has proven to be a formidable and agile competitor, particularly in the U.S. market. The company has successfully built a portfolio of “power brands” around its core ARM & HAMMER franchise and has aggressively expanded into oral care through strategic acquisitions like WaterPik and TheraBreath, which have become significant growth drivers.31 The company reported strong organic sales growth of 4.6% for the full year 2024, indicating its ability to effectively compete and gain share.31

The company’s reliance on emerging markets presents both its greatest long-term opportunity and its most significant near-term risk. The potential for growth in these regions, where per capita consumption of oral and personal care products is still low, is substantial. This is reflected in the company’s disparate growth rates; in Q1 2024, for example, Latin America delivered organic sales growth of 25.9%, while North America grew by a more modest 4.0%.32 However, this exposure creates considerable volatility in reported financial results due to currency fluctuations. A prime example occurred in Q3 2024, when strong organic growth of 14.2% in Latin America was more than offset by a -17.4% headwind from foreign exchange, resulting in a reported net sales decline of 3.2% for the region.26 This dynamic means that the company’s underlying operational performance can be obscured by macroeconomic currency movements, potentially leading the market to apply a discount to its valuation to account for this inherent unpredictability.

Furthermore, while Colgate’s dominance in oral care is a formidable moat, it also represents a significant concentration risk. Oral care products accounted for 43% of the company’s total sales in 2024, making its overall financial health heavily dependent on the performance of this single category.23 In contrast, competitors like P&G are more diversified; its largest segment, Fabric & Home Care, makes up 36% of sales, but it has four other segments that contribute significantly to revenue.33 This means that a disruptive innovation, a sudden shift in consumer preferences (e.g., away from fluoride), or aggressive market share gains by a competitor in the oral care space would have a much more severe impact on Colgate’s overall business than a similar event in one of P&G’s categories would have on its total enterprise. The company’s strategic acquisitions in professional skincare and the continued growth of the Hill’s Pet Nutrition business are logical steps to diversify its revenue base, but these segments remain considerably smaller than the core oral care engine.

MetricColgate-Palmolive (CL)Procter & Gamble (PG)Unilever (UL)Church & Dwight (CHD)
Total Revenue (FY24, USD B)$20.10$84.04$65.75 (€60.8B)$6.11
YoY Revenue Growth (%)3.3%2.5%1.9%4.1%
Organic Sales Growth (%)7.0% (Q4’23)4.0%4.2%4.6%
Gross Profit Margin (%)59.6%51.3%45.0%44.0% (Adjusted)
Operating Margin (%)21.7% (Base Business)25.6%18.4% (Underlying)17.5% (Adjusted)
Global Toothpaste Share (%)41.1%N/AN/AN/A
P/E Ratio (TTM)~22.1x – 23.4x~22.8x – 23.4x~22.9x – 23.8x~40.9x – 43.4x
EV/EBITDA (TTM)~15.0x – 15.2x~15.7x – 16.1x~12.9x – 13.8x~18.6x
Dividend Yield (%)~2.5%~2.8%~3.3%~1.3%
Sources:.28 Note: Data is from latest available full-year 2023 or 2024 reports. Unilever revenue converted from EUR at a rate of 1.08. Ratios are approximate based on data available as of late 2025.

3. Financial Performance & Growth Analysis

A. Revenue Growth Trends

Colgate-Palmolive has a long track record of delivering consistent, albeit moderate, top-line growth. Over the past decade, annual revenue has expanded from $15.20 billion in 2016 to $20.10 billion in fiscal year 2024.37 Recent performance reflects the company’s ability to navigate a complex macroeconomic environment through a combination of pricing actions and volume recovery.

  • 2022: Annual revenue was $17.97 billion, an increase of 3.1% year-over-year.37
  • 2023: Annual revenue grew by a robust 8.3% to $19.46 billion, largely driven by significant pricing actions to offset inflation.37
  • 2024: Annual revenue increased by 3.3% to $20.10 billion, showing a moderation in growth as pricing contributions normalized.37

Growth has been led by the Pet Nutrition segment, which grew 4.5% in 2024, outpacing the 3.0% growth in the larger Oral, Personal and Home Care segment.24 Geographically, the company’s performance highlights its reliance on emerging markets as its primary growth engine. In the second quarter of 2024, organic sales growth was strongest in Latin America (+18.8%) and Africa/Eurasia (+16.4%), while developed markets like North America (+2.5%) and Europe (+6.5%) posted more modest gains.55

B. Profitability Metrics

After a period of margin compression due to significant raw material and logistics cost inflation, Colgate’s profitability metrics have shown a strong recovery, indicating that its pricing and productivity initiatives have been effective.

  • Gross Margin: The company’s gross profit margin has expanded significantly, reaching 60.6% in Q2 2024 and 61.1% in Q3 2024.26 This improvement of 280 to 300 basis points over the prior-year periods is a critical indicator of restored pricing power and successful cost management.
  • Operating Margin: The Base Business (non-GAAP) operating profit margin has remained robust, standing at 22.1% in Q2 2024 and 22.5% in Q3 2024.26
  • Return on Invested Capital (ROIC): Colgate demonstrates exceptionally high capital efficiency. Its ROIC for the last twelve months was 33.9%, a substantial improvement from 28.6% in 2022 and well ahead of peers like P&G (20.2%) and Unilever (15.4%).56 This top-tier ROIC signifies that the underlying business generates very high returns on the capital invested in its operations.
  • Return on Equity (ROE): The company’s reported ROE is an outlier, with various sources citing figures well over 300%.44 This extremely high figure is not solely a reflection of operational profitability but is a direct consequence of the company’s leveraged capital structure. By consistently using debt and cash flow to fund share repurchases, management has systematically reduced the book value of shareholders’ equity. As ROE is calculated by dividing net income by shareholders’ equity, this small denominator mathematically magnifies the return, making ROE a less reliable indicator of core business performance for Colgate than for less-leveraged peers. The superior ROIC is a more direct and meaningful measure of the company’s operational efficiency.

C. Working Capital and Cash Flow

Colgate-Palmolive is a prolific cash flow generator, a hallmark of a mature and efficient consumer staples business.

  • Cash Flow from Operations: For the first nine months of 2024, net cash provided by operations was a strong $2.838 billion.26 For the full year 2023, the company generated $3.745 billion in operating cash flow, a 47% increase over the prior year, reflecting higher earnings and improved working capital management.54
  • Financial Health: The company maintains a leveraged but stable balance sheet. As of its most recent filings, total debt stood between $6.4 billion and $8.8 billion.44 Despite the high debt-to-equity ratio of approximately 8.33, the company’s ability to service this debt is not in question, as evidenced by a strong interest coverage ratio of 15.21.44

The significant gross margin expansion seen throughout 2024 marks a crucial turning point for the company. After enduring a period where the primary focus was on defending margins against rampant inflation, the company has successfully restored its profitability to historical highs. This recovery provides critical financial flexibility. As management has noted in recent earnings calls, the incremental gross profit generated is being used to fund a virtuous cycle of reinvestment.32 Increased advertising spending, which rose 16% in both Q1 and Q3 of 2024, is intended to build brand health and drive volume growth.26 This, in turn, supports the brand’s pricing power, helping to sustain the higher margins. The success of this strategy—turning margin recovery into sustained, volume-led organic growth—will be a key determinant of the company’s performance going forward.

Fiscal YearNet Sales (USD M)Organic Sales Growth (%)Gross Margin (%)Operating Margin (Base, %)Net Income (Base, USD M)Diluted EPS (Base, $)Free Cash Flow (USD M)ROIC (%)
201915,693N/AN/AN/AN/AN/AN/A35.5%
202016,4715.0%60.7%24.3%3,346$3.863,25431.4%
202117,4214.5%59.8%23.4%3,317$3.882,78732.0%
202217,9675.0%56.0%20.9%2,824$3.332,54828.6%
202319,4578.5%58.6%21.3%2,740$3.233,11529.8%
202420,1017.0% (Q4’23)59.6% (Q4’23)21.7% (Q4’23)2,889$3.60N/A33.9%
Sources:.37 Note: Some historical data points were not available in the provided materials. Base Business figures are non-GAAP. FCF calculated as Net Cash from Operations minus Capital Expenditures. 2024 organic growth, margins, and EPS are based on Q4 2023 results as a proxy for the full year.

4. Growth Opportunities & Strategic Initiatives

Colgate-Palmolive’s growth strategy is centered on driving organic sales through science-led innovation, expanding its presence in high-growth markets and channels, and making strategic, bolt-on acquisitions to enhance its portfolio.

A. Innovation and R&D Investment

Innovation is the primary engine for driving growth and defending against private-label competition. The company’s strategy focuses on developing “science-led, core and premium innovation” across all price tiers to increase household penetration and improve brand health.26 This involves launching products with demonstrable, superior benefits that consumers are willing to pay a premium for. In 2024, the company allocated approximately 1.8% of its annual revenue to research and development to support this objective.11 Recent examples include advancements in whitening and sensitivity treatments in oral care and the development of more efficacious formulas in personal and home care. The company is also leveraging technology, with the launch of AI-integrated toothbrushes that provide real-time feedback to users, aiming to enhance the consumer experience and drive adoption of higher-margin products.11

B. Emerging Market Penetration

With a significant portion of its sales already derived from outside North America and Europe, Colgate’s long-term growth is intrinsically linked to its success in emerging markets. The strategy in these regions focuses on increasing household penetration of its core products and encouraging consumers to trade up to more advanced formulations as disposable incomes rise.64 The company leverages its extensive distribution network to reach a wide range of consumers and supports its brands with localized marketing campaigns. In February 2024, Colgate-Palmolive announced a collaboration with a UNICEF-supported platform in India to promote oral health and nutrition awareness among children, an initiative that builds brand equity and drives long-term consumer adoption.11

C. Digital Transformation and E-commerce

The company is actively investing in digital capabilities to adapt to evolving consumer purchasing patterns. E-commerce is a key focus, as it represents a faster-growing channel than traditional retail.1 The company is scaling its capabilities in digital marketing, data, and analytics to better understand consumer behavior and improve the return on its advertising investments.65 Management has highlighted the use of proprietary Revenue Growth Management (RGM) analytics tools to make more informed pricing and promotion decisions, which is particularly crucial in an inflationary environment.66 The company also employs prescriptive analytics and AI to optimize promotion calendars, aiming to maximize volume, revenue, and profit.66

D. Acquisition Strategy

Colgate-Palmolive employs a disciplined acquisition strategy focused on “smart acquisitions” that expand its presence in attractive categories, improve its market positions, and add new capabilities.64 Rather than pursuing large, transformational mergers, the company targets smaller, high-growth brands that complement its existing portfolio. A key example is the expansion into the high-margin professional skincare market through the acquisitions of EltaMD, Filorga, and PCA SKIN.23 In the Pet Nutrition segment, the company recently acquired the Prime100 pet food business to bolster its portfolio.67 These acquisitions are part of a broader strategy to diversify away from the company’s heavy reliance on oral care and tap into new avenues for growth.

5. Capital Allocation & Shareholder Returns

Colgate-Palmolive’s capital allocation philosophy prioritizes reinvesting in the business to drive organic growth, consistently returning cash to shareholders through dividends and share repurchases, and pursuing strategic acquisitions.

A. Dividend Policy

The company has an exceptionally long and consistent history of paying dividends, a cornerstone of its value proposition for investors. Colgate-Palmolive has paid uninterrupted dividends on its common stock every year since 1895 and has increased its dividend payment for 62 consecutive years, demonstrating a steadfast commitment to shareholder returns through all economic cycles.64 The dividend is a key component of the company’s goal to deliver superior total shareholder return.

B. Share Repurchase Programs

In addition to dividends, the company regularly returns value to shareholders through share repurchase programs.64 These programs serve to offset dilution from stock-based compensation and reduce the total number of shares outstanding, thereby increasing earnings per share. The consistent buybacks are a primary driver of the company’s highly leveraged capital structure and the resulting high return on equity. In 2024, the company returned a total of $3.4 billion to shareholders through the combination of dividends and share repurchases.64

C. Capital Expenditures and Investment Priorities

Capital expenditures are directed toward supporting organic growth, enhancing productivity, and modernizing the company’s global supply chain. This includes investments in new manufacturing capacity to support growing product categories like Pet Nutrition, as well as investments in technology to drive simplification, efficiency, and standardization across the organization.64 Management aims for efficient capital spending that generates strong returns and supports the company’s long-term growth and margin expansion goals.

6. Recent Challenges & Industry Headwinds (2022-2024)

Over the past three years, Colgate-Palmolive and the broader consumer staples sector have navigated a series of significant macroeconomic and industry-specific challenges.

A. Supply Chain Disruptions and Inflationary Pressures

The period from 2022 to 2024 was marked by significant global supply chain volatility and broad-based inflation. The company faced rising costs for key raw and packaging material commodities, such as resins, essential oils, tropical oils, and pulp, as well as higher energy and logistics expenses.23 These cost pressures directly compressed gross profit margins. In response, management implemented a strategy of significant price increases across its portfolio, coupled with its ongoing “funding-the-growth” cost-saving initiatives to mitigate the impact on profitability.66 While these actions were successful in restoring margins by 2024, they contributed to challenges in maintaining sales volume.

B. Foreign Exchange Impact

As a global company with a majority of its sales generated outside the United States, Colgate-Palmolive is highly exposed to currency fluctuations. The sustained strength of the U.S. dollar from 2022 through 2024 created a significant headwind for the company’s reported financial results. When international currencies weaken relative to the dollar, sales and profits generated in those currencies translate into fewer U.S. dollars, negatively impacting reported net sales and earnings per share. For example, in Q1 2025, foreign exchange was a 4.4% headwind to net sales.70 Similarly, in Q3 2024, a -17.4% FX impact in Latin America turned 14.2% organic growth into a 3.2% reported sales decline.26 Management regularly provides guidance on the expected impact of foreign exchange, but the inherent volatility remains a key risk for investors and a source of uncertainty in financial forecasting.

C. Shifts in Consumer Behavior

The post-pandemic economic environment, characterized by high inflation and fears of a recession, has led to noticeable shifts in consumer purchasing patterns. Consumers have become more value-conscious, leading to an increase in “trading down” from premium brands to more affordable private-label alternatives, particularly in developed markets.2 This trend puts pressure on branded consumer goods companies like Colgate to justify their price premiums through innovation and effective marketing. In earnings calls, management has acknowledged the slowing category growth in many markets and has emphasized a strategy of fine-tuning promotions and offering products across all price tiers to appeal to consumers who feel less certain about their financial well-being.65

D. Intensifying Competition

The competitive landscape remains intense. In addition to direct competition from large multinational peers like Procter & Gamble and Unilever, Colgate faces pressure from smaller, more agile local competitors in emerging markets and the growing threat from private-label brands.22 The substantial growth of e-commerce has also lowered barriers to entry for new competitors and business models, further intensifying the competitive environment.22

7. Management Quality & Corporate Governance

A. Leadership Team and Strategic Vision

Colgate-Palmolive is led by a seasoned management team with deep industry experience. The Chairman, President, and CEO, Noel R. Wallace, is a long-tenured executive who has been with the company since 1987, holding various leadership roles across different divisions and regions globally before becoming CEO.72 This extensive experience provides a deep understanding of the company’s business and the global consumer landscape.

The strategic vision articulated by management focuses on delivering consistent, compounded earnings per share growth to drive superior total shareholder return.23 The key pillars of this strategy include:

  • Driving Organic Sales Growth: Focusing on science-led innovation, pursuing higher-growth adjacent categories, and expanding in faster-growing channels and markets.64
  • Maximizing Efficiency: Generating savings through ongoing productivity initiatives and investing in technology to drive simplification and standardization.68
  • Effective Capital Deployment: Prioritizing operating cash flow growth, efficient capital spending, consistent dividend growth, share repurchases, and smart acquisitions.64
  • Sustainability and Social Impact: Integrating sustainability into the business strategy with a focus on preserving the environment, helping millions of homes, and driving social impact.64

B. Corporate Governance Practices

The company and its Board of Directors maintain a longstanding commitment to high standards of corporate governance, which are reviewed on an ongoing basis.

  • Board Composition and Independence: The Board consists of ten members, nine of whom are independent under the standards of the New York Stock Exchange.64 The only non-independent director is the CEO. All directors are elected annually.
  • Board Leadership: The Board has a Lead Independent Director, a role that is separate from the Chairman of the Board. The Lead Director is selected by the independent directors for a three-year term and presides over executive sessions of the independent directors, which are held at every regularly scheduled Board meeting.64
  • Board Committees: The Board has four standing committees: Audit; Finance; Nominating, Governance and Corporate Responsibility; and Personnel and Organization. All members of these committees are independent directors, ensuring that independent oversight is applied to critical areas such as financial reporting, risk management, executive compensation, and director nominations.64
  • Executive Compensation: The company’s executive compensation program is designed to align pay with performance, with 75% to 90% of target direct compensation for named executive officers being incentive-based.64 Incentive programs are tied to performance measures that are correlated with long-term shareholder returns, including strategic initiatives focused on innovation and customer experience.64

8. Valuation Analysis

Assessing the valuation of Colgate-Palmolive requires comparing its current market metrics to its historical ranges, its direct peers, and the broader market, while considering its growth prospects and risk profile.

A. Key Valuation Metrics

As of late 2025, Colgate-Palmolive’s valuation metrics are as follows:

  • Price-to-Earnings (P/E) Ratio: The trailing twelve months (TTM) P/E ratio is in the range of 22.1x to 23.4x, with a forward P/E ratio around 21.9x.44
  • Enterprise Value to EBITDA (EV/EBITDA): The TTM EV/EBITDA ratio is approximately 15.0x to 15.2x.45
  • Price-to-Sales (P/S) Ratio: The TTM P/S ratio is approximately 3.2x to 3.4x.44
  • Dividend Yield: The forward dividend yield is approximately 2.5%.73

B. Comparative Valuation

Compared to its peers, Colgate-Palmolive’s valuation appears to be in line with other large-cap consumer staples companies. Its P/E ratio is similar to that of Procter & Gamble (~22.8x) and Unilever (~22.9x), but significantly lower than the more highly valued Church & Dwight (~42.2x).45 The company’s P/S ratio of 3.2x is slightly below its five-year average of 3.8x, suggesting a valuation that is reasonable relative to its own recent history.61 When compared to the S&P 500, Colgate’s P/E (22.2x vs 23.7x) and P/S (3.2x vs 3.3x) ratios are broadly in line with the market average, indicating that it does not trade at a significant premium or discount to the broader market despite its defensive characteristics.61

C. Discounted Cash Flow (DCF) Considerations

A DCF analysis provides an estimate of a company’s intrinsic value based on its future cash flows. For Colgate-Palmolive, key inputs would include:

  • Revenue Growth: Projections should be based on the company’s long-term organic growth target of 3% to 5%, adjusted for expected foreign exchange impacts.
  • Profit Margins: Future margin assumptions should reflect the recent recovery in gross margins and management’s ability to sustain these levels through productivity and pricing.
  • Capital Expenditures: Capital spending is expected to normalize around 2% of sales after a period of elevated investment.75
  • Discount Rate (WACC): The weighted average cost of capital would reflect the company’s low beta (0.35-0.39), indicating lower systematic risk than the overall market, but also its leveraged capital structure.44

One third-party DCF model estimates a fair value of $129.42 per share, suggesting the stock may be significantly undervalued relative to its future cash flow potential.45 While this is just one estimate, it highlights that a valuation based on fundamentals could indicate potential upside.

The company’s valuation is driven by the stability of its earnings, its strong brand equity, and its consistent return of cash to shareholders. However, this is balanced by its moderate growth prospects and the significant, persistent risk of foreign exchange volatility, which may warrant a valuation discount relative to peers with a greater focus on the U.S. market.

9. Risk Assessment

A comprehensive analysis of Colgate-Palmolive must include a thorough assessment of the key risks that could impact its business, financial condition, and future performance.

A. Business and Financial Risks

  • Intense Competition: The company operates in a highly competitive global marketplace against large, well-resourced multinational corporations and agile local players. The growing prevalence of private-label brands, particularly during periods of economic weakness, poses a significant threat to market share and pricing power.22
  • Commodity Price and FX Volatility: The company’s profitability is sensitive to fluctuations in the prices of raw materials, packaging, and energy. Additionally, as a global company with a majority of its sales outside the U.S., its reported results are subject to significant volatility from foreign currency exchange rate movements.23
  • Customer Concentration: A single customer, Walmart Inc., accounted for 11% of the company’s net sales in 2024.23 The loss of, or a significant reduction in business with, this key customer would have a material adverse effect on the company.
  • Portfolio Concentration: The company’s heavy reliance on the oral care category (43% of sales) makes it more vulnerable to category-specific downturns or competitive disruptions compared to more diversified peers.23

B. Regulatory and Compliance Risks

Colgate-Palmolive is subject to extensive governmental regulations in the U.S. and abroad, covering aspects such as product development, ingredients, manufacturing, packaging, labeling, advertising, and environmental impact.22 The company is also subject to anti-corruption laws, including the U.S. Foreign Corrupt Practices Act. Changes in these regulations or failure to comply could result in significant costs, penalties, or business disruptions.22

C. Execution and Strategic Risks

The company’s success depends on its ability to execute its strategic initiatives effectively. This includes successfully launching new products, integrating acquisitions, and realizing the expected savings and efficiencies from its productivity programs.67 Failure to achieve these objectives could hinder growth and profitability. Furthermore, the company faces cybersecurity risks, which are managed by its Enterprise Risk Management Committee as a critical priority.22

10. Key Metrics to Monitor

To assess the ongoing performance and strategic execution of Colgate-Palmolive, investors should monitor the following key metrics on a quarterly and annual basis:

  • Organic Sales Growth: This is the most important measure of underlying business momentum as it strips out the volatility of foreign exchange and the impact of acquisitions/divestitures. Particular attention should be paid to the breakdown between volume growth and price/mix. A healthy balance is preferable to growth driven solely by pricing.
  • Market Share Trends: Monitoring the company’s global market share in its core categories of toothpaste and manual toothbrushes is critical to assessing the health of its primary economic moat. Any sustained decline in these figures would be a significant concern.
  • Gross Margin Progression: The ability to sustain gross margins at or above the 60% level is a key indicator of pricing power and cost control. This metric directly impacts the company’s ability to reinvest in advertising and innovation.
  • Free Cash Flow Generation and Conversion: Consistent and strong free cash flow is the foundation of the company’s capital allocation strategy. Monitoring free cash flow and its conversion from net income is essential to evaluating the company’s ability to fund dividends, share buybacks, and acquisitions.
  • Advertising Spend as a Percentage of Sales: Tracking this metric indicates whether management is following through on its commitment to reinvest in brand building. A rising percentage, funded by gross margin expansion, would be a positive sign of the company’s virtuous cycle strategy at work.
  • Performance of Strategic Growth Initiatives: The growth rates of the Pet Nutrition segment and the professional skincare brands (EltaMD, Filorga, PCA SKIN) should be monitored to assess the success of the company’s diversification efforts.

Frequently Asked Questions

Of course. Here are the answers to your follow-up questions based on the analysis.

  • Are earnings at a cyclical high or cyclical low? Earnings are recovering from a cyclical low. After a period of significant margin compression due to raw material and logistics cost inflation in 2022 and 2023, profitability has shown a strong recovery in 2024. Gross margins have expanded significantly, which is a key indicator that the company has successfully managed costs and implemented effective pricing strategies, putting earnings on an upward trajectory from the recent trough.  
  • Are earnings driven primarily by the external environment (commodity producer), or internal company actions? While the external environment (inflation, foreign exchange rates, supply chain costs) creates significant headwinds or tailwinds, the recent recovery in earnings has been driven primarily by internal company actions. Management has successfully implemented significant price increases, ongoing cost-saving initiatives, and productivity improvements to counteract external inflationary pressures. Furthermore, the company is reinvesting the resulting gross profit gains into increased advertising to drive volume growth, a key internal strategy to create a “virtuous cycle” of growth.
  • Can this business be easily understood? Yes, the business model is straightforward and can be easily understood. The company operates in two primary segments: Oral, Personal and Home Care (selling everyday products like toothpaste, soap, and cleaners) and Pet Nutrition (selling premium, science-based pet food). Its revenue is generated from the sale of these essential consumer goods through a global distribution network.  
  • Can this company be undermined by foreign, low-cost labor? The more direct threat is not from low-cost labor in its own manufacturing but from low-cost local competitors, particularly in emerging markets. In many rural areas, consumers may opt for traditional, low-cost alternatives (like neem sticks for oral care) or products from local producers that can be priced 30-50% lower than multinational brands. This dynamic pressures Colgate’s pricing power and requires continuous innovation and brand investment to justify its premium.  
  • Do brands matter in the business? Or is this a commodity producer? Brands are paramount; this is not a commodity business. The company’s primary competitive advantage is its powerful brand equity, built over decades. The “Colgate” brand is one of the most recognized consumer brands globally and is synonymous with oral care, which provides immense pricing power and consumer trust. This brand strength is a key barrier to entry for competitors.  
  • Does the company have assets that are not fully recognized in the balance sheet? Yes. The company’s most valuable asset—its brand equity, particularly the “Colgate” brand name—is not fully reflected on the balance sheet. While the balance sheet includes goodwill and intangible assets from acquisitions, the immense value of its organically grown, globally recognized brands is a significant off-balance-sheet asset that underpins its economic moat.
  • Does the company issue large amounts of new shares to insiders? No, the amount of share-based compensation is not large relative to earnings. In 2024, stock-based compensation was approximately $135 million. Compared to the net income of $2.89 billion for the same year, this represents about 4.7% of net income, which is well below a 10% threshold. The company also actively repurchases shares to offset this dilution.  
  • Has the business environment changed recently? Yes, the business environment has been volatile. The period from 2022 to 2024 was marked by significant challenges, including high raw material and logistics cost inflation, supply chain disruptions, considerable negative impacts from a strong U.S. dollar, and shifts in consumer behavior toward more value-conscious purchasing in response to economic uncertainty.  
  • Has the company made any significant acquisitions recently? Yes. In February 2025, the company announced an agreement to acquire Prime100, a fresh pet food brand in Australia, to enter the fast-growing fresh pet food category. This follows a significant $700 million investment in August 2022 to purchase three dry pet food manufacturing plants from Red Collar Pet Foods to increase capacity for its Hill’s Pet Nutrition business.  
  • Has the company recently changed accounting policies? The company has not changed its fundamental accounting policies recently. However, effective July 1, 2024, it did change its geographic segment reporting structure. The results of its professional skincare business, which were previously reported within the Europe segment, are now reported within the North America segment. Historical segment information has been recast to reflect this change.  
  • How CapEx hungry is this business? What % of cash from operations must be spent on CapEx to sustain the business? The business is not capital expenditure-intensive. Based on financial data from recent years, capital expenditures as a percentage of cash from operations have been:
    • 2024: 13.7% ($561M in CapEx / $4,107M in CFO)  
    • 2023: 18.8% ($705M in CapEx / $3,745M in CFO)  
    • 2022: 27.2% ($696M in CapEx / $2,556M in CFO)  
    • This low percentage demonstrates the business’s ability to generate strong cash flow without requiring heavy reinvestment into physical assets.
  • How conservative is the company’s accounting? Are they over- or under- stating earnings? Based on the available information, the company’s accounting appears to be conservative and in line with standard industry practice. The company provides non-GAAP “Base Business” metrics to supplement its GAAP reporting, with clear reconciliations, which is a common and transparent practice. There are no red flags in the financial reports to suggest earnings are being materially overstated or understated.
  • How many options / shares is the management issuing to insiders? Is it more than 10% of net income? Stock-based compensation to insiders is not more than 10% of net income. In 2024, it was approximately $135 million, which is about 4.7% of the $2.89 billion in net income for that year.  
  • How much free cash flow does the business generate? How does management use this free cash flow? What is their philosophy? The business is a strong generator of free cash flow. In 2024, it generated approximately $3.55 billion in free cash flow. Management’s capital allocation philosophy is to first reinvest in the business to drive organic growth (through R&D, advertising, and capital expenditures), and then return the remaining cash to shareholders through consistent dividends and share repurchases. The company also uses cash for strategic, bolt-on acquisitions.  
  • How profitable is this business? What is the return on capital invested? Return on equity? The business is highly profitable.
    • Return on Invested Capital (ROIC): The company’s ROIC is exceptionally high at 33.9%, indicating very efficient use of capital to generate profits.  
    • Return on Equity (ROE): The reported ROE is over 300%. This figure is artificially inflated due to the company’s strategy of using debt and cash flow to repurchase shares, which has significantly reduced the book value of its equity. ROIC is a more meaningful measure of its core operational profitability.
  • How profitable is this industry? Are there a lot of competitors? What are the barriers to entry? The consumer staples industry is generally profitable, characterized by stable demand. There are many large, well-resourced competitors, including Procter & Gamble, Unilever, and Church & Dwight, as well as smaller local players and private-label brands. Barriers to entry are formidable and include massive brand equity built over decades, extensive global distribution networks, large advertising budgets, and established relationships with major retailers.  
  • How stable are revenues? How much do they fluctuate with the economy? Revenues are very stable. As a consumer staples company, its products have non-cyclical, consistent demand regardless of economic conditions. This defensive characteristic was demonstrated during the market downturns in 2020 and 2022, where the stock performed better than the broader market. The company’s downturn resilience is rated as “Strong”.  
  • Is net income diverging from cash from operations? No, there is no negative divergence. Cash from operations has consistently been significantly higher than net income in recent years, which is a sign of healthy earnings quality and efficient working capital management.  
  • Is the company buying back shares? Paying dividends? Yes, the company does both consistently. It has a 62-year history of annual dividend increases and maintains an ongoing share repurchase program. In 2024, the company returned a combined $3.4 billion to shareholders through these two methods.  
  • Is the stock and ADR? What are the ADR fees? The stock is not an American Depositary Receipt (ADR). Colgate-Palmolive Co. is a U.S. company, and its common stock trades directly on the New York Stock Exchange (NYSE) under the ticker symbol CL. Therefore, there are no ADR fees.  
  • Outlook for the company’s products and services? How big will this market be? Is it growing? Domestic or international? The outlook is for steady growth in large, international markets. The global oral care market is valued at over $33 billion, the personal care market at over $379 billion, and the pet nutrition market at over $126 billion. All are projected to grow at a compound annual growth rate (CAGR) of 4–7%. Growth is particularly strong in emerging international markets like the Asia-Pacific region.  
  • Recent changes in the business, new markets, new production facilities, what’s changed recently? New management?
    • Recent Business Changes: The company launched a new three-year productivity program in August 2025 focused on optimizing its global supply chain. It is also navigating a volatile environment of slowing category growth and consumer uncertainty.  
    • New Facilities: The company has recently invested in expanding its manufacturing capacity, particularly for its Hill’s Pet Nutrition business, with a new plant in Kansas, an acquisition in Italy, and the purchase of three U.S. plants from a competitor.  
    • New Management: There have been recent changes in the leadership team. In 2025, Shane Grant joined as Chief Operating Officer, Americas, and John Hazlin was appointed Chief Growth Officer.  
  • What are the motivations of management? Do they own a lot of stock and options? Management’s motivation is strongly tied to company performance and shareholder returns. Between 75% and 90% of executive compensation is incentive-based, linked to strategic goals and business results. While direct insider ownership is relatively low (under 2%), which is common for a company of this size, the compensation structure is designed to align management’s interests with those of shareholders.  
  • What are the recent news on the company? Recent news includes the announcement of a quarterly dividend, an agreement to acquire the Prime100 fresh pet food brand, and the launch of a new supply chain productivity program. Analyst commentary has been mixed, with some firms lowering price targets while others maintain positive ratings, reflecting the challenging but resilient operating environment.  
  • What factors would cause the stock to decline? Are these factors controlled by the company or the external environment? The stock could decline due to a mix of external and internal factors.
    • External Factors: A global recession leading to widespread consumer trade-down, significant adverse foreign currency movements, or a sharp spike in commodity costs.
    • Internal Factors: Failure to innovate effectively, a loss of market share to competitors (like P&G or private labels), or poor execution of strategic initiatives.
  • What is the nature of competition? Do brand names matter? What are the customers switching costs? Competition is intense and comes from large global peers (P&G, Unilever), agile local competitors, and private-label brands. Brand names are critically important and are the company’s main defense. Customer switching costs are essentially zero, as a consumer can easily choose a different brand on any given shopping trip. This makes brand loyalty, built through advertising and product performance, essential for sustained success.
  • What is the risk of a catastrophic loss on this investment? What is the chance of a total loss? The risk of a catastrophic or total loss is extremely low. The company is a leader in the defensive consumer staples sector, sells essential products with stable demand, has a strong balance sheet, and a very low probability of bankruptcy (as indicated by a high Altman Z-Score of 6.85). A total loss would require an unforeseen, existential event.  
  • What off B/S liabilities does the company have? The company’s financial filings do not indicate any material off-balance sheet arrangements or liabilities.  
  • What is the compensation policy of directors and management? The compensation policy is performance-based, designed to align the interests of executives and shareholders. For senior executives, 75% to 90% of compensation is incentive-based, tied to metrics that correlate with long-term shareholder returns, such as organic sales growth and earnings growth. Non-employee directors receive a combination of cash retainers and equity awards.  

Works cited

  1. Consumer Staples Market Size, Share, Growth 2033 – Business Research Insights, accessed September 24, 2025, https://www.businessresearchinsights.com/market-reports/consumer-staples-market-120621
  2. Consumer Staples Sector Report 2023-24 | Trinity SMF, accessed September 24, 2025, https://trinitysmf.com/wp-content/uploads/2023/10/Consumer-Staples-Sector-Report-2023-24.pdf
  3. Staple Market Size, Share & Forecast Report 2034, accessed September 24, 2025, https://www.marketresearchfuture.com/reports/staple-market-12629
  4. Consumer Staples Sector: A Place in Portfolios | Morgan Stanley, accessed September 24, 2025, https://www.morganstanley.com/im/en-ch/intermediary-investor/insights/articles/the-case-for-consumer-staples.html
  5. Oral Care Market Size, Share, Trends, Forecast Report, 2032, accessed September 24, 2025, https://www.fortunebusinessinsights.com/oral-care-market-103533
  6. Oral Care Market Size & Growth Forecast to 2030 – MarketsandMarkets, accessed September 24, 2025, https://www.marketsandmarkets.com/Market-Reports/oral-care-market-80546246.html
  7. Oral Care Market Size to Hit USD 80.8 Billion by 2034 – Precedence Research, accessed September 24, 2025, https://www.precedenceresearch.com/oral-care-market
  8. Oral Care Market Size, Share | Industry Report, 2030 – Grand View Research, accessed September 24, 2025, https://www.grandviewresearch.com/industry-analysis/oral-care-market
  9. Oral Care Market Size, Trends, Report & Share Analysis 2025-2030 – Mordor Intelligence, accessed September 24, 2025, https://www.mordorintelligence.com/industry-reports/oral-care-market
  10. Oral Care Market worth $53.29 billion by 2030 – MarketsandMarkets, accessed September 24, 2025, https://www.marketsandmarkets.com/PressReleases/oral-care.asp
  11. Colgate-Palmolive (US) and Procter & Gamble (US) are Leading players in the Oral Care Market – MarketsandMarkets, accessed September 24, 2025, https://www.marketsandmarkets.com/ResearchInsight/oral-care-market.asp
  12. Personal Care Products Market Size, Share | Growth [2032], accessed September 24, 2025, https://www.fortunebusinessinsights.com/personal-care-products-market-112095
  13. Beauty and Personal Care Products Market Size, Share and Forecast to 2033, accessed September 24, 2025, https://straitsresearch.com/report/beauty-and-personal-care-products-market
  14. Beauty and Personal Care Products Market Report, 2030 – Grand View Research, accessed September 24, 2025, https://www.grandviewresearch.com/industry-analysis/beauty-personal-care-products-market
  15. Beauty and Personal Care Products Market Size, 2033 – IMARC Group, accessed September 24, 2025, https://www.imarcgroup.com/beauty-personal-care-products-market
  16. Beauty And Personal Care Products Market Size & Outlook, 2030 – Grand View Research, accessed September 24, 2025, https://www.grandviewresearch.com/horizon/outlook/beauty-and-personal-care-products-market-size/global
  17. Home Care in the US | Market Research Report | Euromonitor, accessed September 24, 2025, https://www.euromonitor.com/home-care-in-the-us/report
  18. Pet Food Market Size, Growth, Share, Trends, Analysis, 2032 – Fortune Business Insights, accessed September 24, 2025, https://www.fortunebusinessinsights.com/industry-reports/pet-food-market-100554
  19. Pet Food and Supplements Market Size to Hit USD 200.39 Bn by 2034, accessed September 24, 2025, https://www.precedenceresearch.com/pet-food-and-supplements-market
  20. Top 15 Companies in Pet Food Market Revenue Report 2035, accessed September 24, 2025, https://www.sphericalinsights.com/blogs/discover-top-15-companies-in-pet-food-market-global-share-market-size-revenue-report-2024-2035
  21. 2024 US Pet Food Sales, accessed September 24, 2025, https://truthaboutpetfood.com/2024-us-pet-food-sales/
  22. Form 10-K for Colgate Palmolive CO filed 02/15/2024, accessed September 24, 2025, https://investor.colgatepalmolive.com/static-files/30bd7719-f7dc-4666-8bbc-0c6d71dbcfdc
  23. Annual Report for Fiscal Year Ending December 31, 2024 (Form 10-K), accessed September 24, 2025, https://www.publicnow.com/view/B533DEFE61A71A8A75F3FDD3A924F8B99046CF0B?1739483314
  24. Colgate-Palmolive Company Revenue Breakdown By Segment – Bullfincher.io, accessed September 24, 2025, https://bullfincher.io/companies/colgate-palmolive-company/revenue-by-segment
  25. Colgate-Palmolive Co in Pet Care | Market Research Report – Euromonitor International, accessed September 24, 2025, https://www.euromonitor.com/colgate-palmolive-co-in-pet-care/report
  26. Colgate Announces 3rd Quarter 2024 Results, accessed September 24, 2025, https://investor.colgatepalmolive.com/news-releases/news-release-details/colgate-announces-3rd-quarter-2024-results/
  27. Consumers and Grow Markets | P&G 2024 Annual Report, accessed September 24, 2025, https://us.pg.com/annualreport2024/superiority-to-win-with-consumers-and-grow-markets/
  28. Fiscal Year 2024 Results | P&G 2024 Annual Report, accessed September 24, 2025, https://us.pg.com/annualreport2024/introduction-and-fy-results/
  29. Personal Care / UNILEVER INVESTOR EVENT 2024, accessed September 24, 2025, https://www.unilever.com/files/unilever-investor-event-2024-personal-care.pdf
  30. Investor Relations full year 2024 Overview | Unilever, accessed September 24, 2025, https://www.unilever.com/investors/results-presentations-webcasts/overview-q4-2024/
  31. Church & Dwight Reports Fourth Quarter … – Church & Dwight Co., Inc., accessed September 24, 2025, https://investor.churchdwight.com/Investors/news/news-details/2025/Church–Dwight-Reports-Fourth-Quarter-and-Full-Year-2024-Results/default.aspx
  32. Colgate Announces 1st Quarter 2024 Results, accessed September 24, 2025, https://investor.colgatepalmolive.com/news-releases/news-release-details/colgate-announces-1st-quarter-2024-results/
  33. Annual Report 2024 | Procter and Gamble, accessed September 24, 2025, https://us.pg.com/annualreport2024/
  34. THE PROCTER & GAMBLE COMPANY AR 2024 – ProxyVote.com, accessed September 24, 2025, https://materials.proxyvote.com/Approved/742718/20240809/AR_584166/INDEX.HTML?page=1
  35. Unilever plc 2024 Final Results February 13, 2025 – James Sharp & Co., accessed September 24, 2025, https://www.jamessharp.co.uk/market-news/unilever-plc-2024-final-results/
  36. Church & Dwight Co., Inc. (CHD) Stock Price, Market Cap, Segmented Revenue & Earnings – Marketreportanalytics.com, accessed September 24, 2025, https://www.marketreportanalytics.com/companies/CHD
  37. Colgate-Palmolive Revenue 2010-2025 | CL – Macrotrends, accessed September 24, 2025, https://www.macrotrends.net/stocks/charts/CL/colgate-palmolive/revenue
  38. Colgate-Palmolive Company Revenue 2015-2024 – Bullfincher.io, accessed September 24, 2025, https://bullfincher.io/companies/colgate-palmolive-company/revenue
  39. Procter & Gamble Revenue 2010-2025 | PG – Macrotrends, accessed September 24, 2025, https://www.macrotrends.net/stocks/charts/PG/procter-gamble/revenue
  40. Procter & Gamble Company Revenue 2016-2025 – Bullfincher.io, accessed September 24, 2025, https://bullfincher.io/companies/the-procter-gamble-company/revenue
  41. Unilever Revenue 2010-2025 | UL – Macrotrends, accessed September 24, 2025, https://macrotrends.net/stocks/charts/UL/unilever/revenue
  42. Unilever (UL) Revenue 2015-2025 – Stock Analysis, accessed September 24, 2025, https://stockanalysis.com/stocks/ul/revenue/
  43. Church & Dwight Co. (CHD) Revenue 2015-2025 – Stock Analysis, accessed September 24, 2025, https://stockanalysis.com/stocks/chd/revenue/
  44. Colgate-Palmolive Company (LON:0P59) Statistics & Valuation Metrics – Stock Analysis, accessed September 24, 2025, https://stockanalysis.com/quote/lon/0P59/statistics/
  45. Colgate-Palmolive (NYSE:CL) Stock Valuation, Peer Comparison & Price Targets, accessed September 24, 2025, https://simplywall.st/stocks/us/household/nyse-cl/colgate-palmolive/valuation
  46. NYSE: PG – PROCTER & GAMBLE stock analysis and financials – FullRatio, accessed September 24, 2025, https://fullratio.com/stocks/nyse-pg/procter-gamble
  47. The Procter & Gamble Company (PG) Statistics & Valuation – Stock Analysis, accessed September 24, 2025, https://stockanalysis.com/stocks/pg/statistics/
  48. Procter & Gamble (NYSE:PG) Stock Valuation, Peer Comparison & Price Targets, accessed September 24, 2025, https://simplywall.st/stocks/us/household/nyse-pg/procter-gamble/valuation
  49. Unilever (UL) Statistics & Valuation – Stock Analysis, accessed September 24, 2025, https://stockanalysis.com/stocks/ul/statistics/
  50. Unilever (LON:ULVR) Statistics & Valuation Metrics – Stock Analysis, accessed September 24, 2025, https://stockanalysis.com/quote/lon/ULVR/statistics/
  51. Unilever (LSE:ULVR) Stock Valuation, Peer Comparison & Price Targets – Simply Wall St, accessed September 24, 2025, https://simplywall.st/stocks/gb/household/lse-ulvr/unilever-shares/valuation
  52. Church & Dwight Co., Inc. – Enterprise Value – Wisesheets, accessed September 24, 2025, https://www.wisesheets.io/enterprise-value/CHD
  53. CHD – Church & Dwight Co., Inc Stock Price and Quote – FINVIZ.com, accessed September 24, 2025, https://finviz.com/quote.ashx?t=CHD
  54. Colgate Announces 4th Quarter and Full Year 2023 Results, accessed September 24, 2025, https://investor.colgatepalmolive.com/news-releases/news-release-details/colgate-announces-4th-quarter-and-full-year-2023-results/
  55. Colgate Announces 2nd Quarter 2024 Results, accessed September 24, 2025, https://investor.colgatepalmolive.com/news-releases/news-release-details/colgate-announces-2nd-quarter-2024-results/
  56. Return on Invested Capital For Colgate-Palmolive Company (CL) – Finbox, accessed September 24, 2025, https://finbox.com/NYSE:CL/explorer/roic/
  57. Return on Invested Capital For Procter & Gamble Company (PG) – Finbox, accessed September 24, 2025, https://finbox.com/NYSE:PG/explorer/roic/
  58. Return on Invested Capital For Unilever PLC ADR (UL) – Finbox, accessed September 24, 2025, https://finbox.com/NYSE:UL/explorer/roic/
  59. CL (Colgate-Palmolive Co) ROE % – GuruFocus, accessed September 24, 2025, https://www.gurufocus.com/term/roe/CL
  60. Colgate-Palmolive Company – ROE – Wisesheets, accessed September 24, 2025, https://www.wisesheets.io/roe/CL
  61. Buy, Sell, or Hold Colgate-Palmolive Stock? | Trefis, accessed September 24, 2025, https://www.trefis.com/stock/cl/articles/575838/buy-sell-or-hold-colgate-palmolive-stock/2025-09-23
  62. Colgate-Palmolive (CL) Q2 2024 Earnings Call Transcript | Seeking Alpha, accessed September 24, 2025, https://seekingalpha.com/article/4707156-colgate-palmolive-cl-q2-2024-earnings-call-transcript
  63. CHURCH & DWIGHT CO., INC. – annual report – SEC.gov, accessed September 24, 2025, https://www.sec.gov/Archives/edgar/data/313927/000119312523073974/d462091dars.pdf
  64. Colgate-Palmolive Company – DEF 14A – SEC.gov, accessed September 24, 2025, https://www.sec.gov/Archives/edgar/data/21665/000130817925000223/cl013539-def14a.htm
  65. Earnings call transcript: Colgate-Palmolive beats Q2 2025 earnings forecast – Investing.com, accessed September 24, 2025, https://www.investing.com/news/transcripts/earnings-call-transcript-colgatepalmolive-beats-q2-2025-earnings-forecast-93CH-4166149
  66. Events & Webcasts | Colgate-Palmolive Company, accessed September 24, 2025, https://investor.colgatepalmolive.com/events-and-webcasts/
  67. Colgate-Palmolive Company Announces 2nd Quarter 2025 Results, accessed September 24, 2025, https://investor.colgatepalmolive.com/news-releases/news-release-details/colgate-palmolive-company-announces-2nd-quarter-2025-results/
  68. colgate-palmolive company – SEC.gov, accessed September 24, 2025, https://www.sec.gov/Archives/edgar/data/21665/000120677421000803/cl3838841-def14a.htm
  69. Colgate-Palmolive Company (CL) Q4 2024 Earnings Call Transcript | Seeking Alpha, accessed September 24, 2025, https://seekingalpha.com/article/4753876-colgate-palmolive-company-cl-q4-2024-earnings-call-transcript
  70. Colgate Announces 1st Quarter 2025 Results, accessed September 24, 2025, https://investor.colgatepalmolive.com/news-releases/news-release-details/colgate-announces-1st-quarter-2025-results/
  71. Colgate-Palmolive Company (CL) Q1 2025 Earnings Call Transcript | Seeking Alpha, accessed September 24, 2025, https://seekingalpha.com/article/4778261-colgate-palmolive-company-cl-q1-2025-earnings-call-transcript
  72. CL Investor Relations – Colgate-Palmolive Co – Alpha Spread, accessed September 24, 2025, https://www.alphaspread.com/security/nyse/cl/investor-relations
  73. Colgate-Palmolive Company (CL) – Profile & Key Metrics – AlphaQuery, accessed September 24, 2025, https://www.alphaquery.com/stock/CL/profile-key-metrics
  74. CHD – Church & Dwight PE ratio, current and historical analysis – FullRatio, accessed September 24, 2025, https://fullratio.com/stocks/nyse-chd/pe-ratio
  75. Church & Dwight Reports Fourth Quarter and Full Year 2024 Results, accessed September 24, 2025, https://s203.q4cdn.com/233583214/files/doc_news/Church–Dwight-Reports-Fourth-Quarter-and-Full-Year-2024-Results-2025.pdf